Pancreatic Cancer Research

ResearcherThe University of Texas at San Antonio Health Science CenterActive in the last 2 years

Daohong Zhou

ORCID-verified (high confidence, 0.95), identity_conf@1As of 6 November 2026

Matched on ORCID iD 0000-0002-2400-6461; OpenAlex author ID A5100781093; NIH RePORTER profile ID 1895063. Sources: OpenAlex.

Their work

Papers
6 (first author 0, last author 2)
Trials
0
Grants
1
Labs led
1
Collaborators
21
Papers, trials and grants by year

2022: 2 papers · 2023: 1 paper, 1 grant · 2024: none · 2025: 2 papers · 2026: 1 paper

Papers 6

  1. The Combination of a BCL-xL PROTAC and an mTOR Inhibitor Sensitizes Pancreatic Ductal Adenocarcinoma to KRAS G12D Inhibitor Treatment. Co-author DOI 10.3390/cancers18060920↗
  2. A novel regimen for pancreatic ductal adenocarcinoma targeting MEK, BCL-xL, and EGFR. Co-author DOI 10.1016/j.neo.2024.101070↗
  3. Targeting DDR2 for Treating Pancreatic Cancer. Co-author DOI 10.1158/1535-7163.mct-24-1226↗
  4. Targeting KRAS in pancreatic cancer: Emerging therapeutic strategies. Last author DOI 10.1016/bs.acr.2023.02.004↗
  5. XP-524 is a dual-BET/EP300 inhibitor that represses oncogenic KRAS and potentiates immune checkpoint inhibition in pancreatic cancer. Co-author DOI 10.1073/pnas.2116764119↗
  6. Overcoming Gemcitabine Resistance in Pancreatic Cancer Using the BCL-XL-Specific Degrader DT2216. Last author DOI 10.1158/1535-7163.mct-21-0474↗

Grants 1

  1. Use of BCL-xL Proteolysis targeting chimeras to treat pancreatic cancer R01CA242003↗

Closest collaborators

The 21 strongest of 21 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Guangrong Zheng · 3 shared papers, 1 shared grant, 2022–2026 · strength 1.28
  2. Jose Gilberto Trevino · 3 shared papers, 1 shared grant, 2022–2025 · strength 1.10
  3. Sajid Ullah Khan · 4 shared papers, 2022–2026 · strength 0.92
  4. Javed Miyan · 1 shared paper, 2026 · strength 0.30
  5. Vignesh Vudatha · 1 shared paper, 2026 · strength 0.30
  6. Dinesh Thummuri · 2 shared papers, 2022 · strength 0.25
  7. Patrick W. Underwood · 2 shared papers, 2022 · strength 0.25
  8. Song Han · 1 shared paper, 2025 · strength 0.24
  9. Gerik W. Tushoski-Alemán · 1 shared paper, 2025 · strength 0.24
  10. Steven J. Hughes · 1 shared paper, 2025 · strength 0.24
  11. Thomas J. George · 1 shared paper, 2025 · strength 0.24
  12. Chris T.P. Do · 1 shared paper, 2025 · strength 0.19
  13. Manjeet K. Rao · 1 shared paper, 2025 · strength 0.19
  14. Deepika Singh · 1 shared paper, 2025 · strength 0.19
  15. Pei Wang · 1 shared paper, 2025 · strength 0.19
  16. Daniel R. Principe · 1 shared paper, 2022 · strength 0.13
  17. Thao D. Pham · 1 shared paper, 2022 · strength 0.13
  18. Suneel Deepak Kamath · 1 shared paper, 2022 · strength 0.13
  19. Ajay Nmn Rana · 1 shared paper, 2022 · strength 0.13
  20. Hidayatullah G. Munshi · 1 shared paper, 2022 · strength 0.13
  21. Andrea N. Riner · 1 shared paper, 2022 · strength 0.12

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.